ANI Pharmaceuticals, Inc. Reports Net Revenues of $6.2 Million and Adjusted Non-GAAP EBITDA of $1.2 Million for the Second Quarter Ended June 30, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAUDETTE, Minn., Aug. 9, 2013 -- /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) today reported results for the three and six months ended June 30, 2013.

Second quarter and first half highlights include:

• Second quarter net revenues of $6.2 million increased 19% versus $5.2 million for the same period in 2012.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC